Dolby Laboratories (NYSE:DLB) major shareholder Dagmar Dolby sold 50,000 shares of the business’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $49.00, for a total value of $2,450,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Thursday, August 24th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $48.98, for a total value of $4,898,000.00.
  • On Tuesday, August 22nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $48.28, for a total transaction of $4,828,000.00.
  • On Friday, August 18th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $48.82, for a total transaction of $4,882,000.00.
  • On Wednesday, August 16th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $49.71, for a total transaction of $4,971,000.00.
  • On Monday, August 14th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $50.19, for a total transaction of $5,019,000.00.
  • On Wednesday, August 9th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.20, for a total transaction of $2,560,000.00.
  • On Thursday, August 10th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $50.84, for a total transaction of $5,084,000.00.
  • On Monday, August 7th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.26, for a total transaction of $2,563,000.00.
  • On Tuesday, August 8th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.13, for a total transaction of $5,113,000.00.
  • On Friday, August 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.13, for a total transaction of $5,113,000.00.

Shares of Dolby Laboratories (NYSE:DLB) opened at 50.17 on Monday. The stock’s 50 day moving average is $51.14 and its 200 day moving average is $50.79. The stock has a market capitalization of $5.15 billion, a PE ratio of 25.66 and a beta of 0.79. Dolby Laboratories has a 52 week low of $44.99 and a 52 week high of $55.02.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings results on Tuesday, July 25th. The electronics maker reported $0.75 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.10. Dolby Laboratories had a net margin of 19.02% and a return on equity of 10.25%. The firm had revenue of $305.67 million for the quarter, compared to analyst estimates of $296.88 million. During the same period in the prior year, the firm posted $0.62 earnings per share. The company’s quarterly revenue was up 10.1% compared to the same quarter last year. Analysts anticipate that Dolby Laboratories will post $1.99 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Monday, August 7th were given a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a yield of 1.12%. The ex-dividend date of this dividend was Thursday, August 3rd. Dolby Laboratories’s dividend payout ratio (DPR) is currently 28.57%.

ILLEGAL ACTIVITY WARNING: “Dolby Laboratories (DLB) Major Shareholder Sells $2,450,000.00 in Stock” was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this story can be viewed at https://theolympiareport.com/2017/08/28/dolby-laboratories-dlb-major-shareholder-sells-2450000-00-in-stock.html.

A number of hedge funds have recently bought and sold shares of the company. Watermark Asset Management Inc. purchased a new stake in Dolby Laboratories during the first quarter valued at about $114,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Dolby Laboratories by 9.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,331 shares of the electronics maker’s stock valued at $114,000 after buying an additional 209 shares during the period. James Investment Research Inc. purchased a new stake in Dolby Laboratories during the first quarter valued at about $155,000. US Bancorp DE raised its stake in Dolby Laboratories by 4.8% in the first quarter. US Bancorp DE now owns 2,951 shares of the electronics maker’s stock valued at $155,000 after buying an additional 135 shares during the period. Finally, The Manufacturers Life Insurance Company raised its stake in Dolby Laboratories by 25.5% in the second quarter. The Manufacturers Life Insurance Company now owns 3,564 shares of the electronics maker’s stock valued at $174,000 after buying an additional 725 shares during the period. 51.87% of the stock is currently owned by hedge funds and other institutional investors.

DLB has been the subject of several research reports. B. Riley set a $62.00 price objective on shares of Dolby Laboratories and gave the company a “buy” rating in a research note on Friday, August 18th. BidaskClub raised shares of Dolby Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, July 8th. Finally, Zacks Investment Research raised shares of Dolby Laboratories from a “sell” rating to a “hold” rating in a research note on Tuesday, July 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $54.38.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with Analyst Ratings Network's FREE daily email newsletter.